RetinalGenix Technologies Inc. SEC filings RTGN
RetinalGenix Technologies Inc. has 114 filings in SEC EDGAR's recent list, going back to Feb 16, 2021. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 15, 2026 (auditor change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Auditor change
|
Jul 15, 2026 | Jul 13, 2026 |
| 144 | Notice of proposed sale | Jun 10, 2026 | — |
| 10-Q | Quarterly report | May 20, 2026 | Mar 31, 2026 |
| NT 10-Q | Filing | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Apr 15, 2026 | Dec 31, 2025 |
| NT 10-K | Filing | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 26, 2026 | Mar 22, 2026 |
| 144 | Notice of proposed sale | Feb 25, 2026 | — |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 144 | Notice of proposed sale | Nov 7, 2025 | — |
| 10-Q/A | Amended quarterly report | Aug 20, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | Aug 19, 2025 | Jun 30, 2025 |
| NT 10-Q | Filing | Aug 14, 2025 | Jun 30, 2025 |
| 144 | Notice of proposed sale | Aug 12, 2025 | — |
| EFFECT | Filing | Jun 27, 2025 | — |
| EFFECT | Filing | Jun 27, 2025 | — |
| POS AM | Filing | Jun 23, 2025 | — |
| POS AM | Filing | Jun 23, 2025 | — |
| POS AM | Filing | Jun 20, 2025 | — |
| POS AM | Filing | Jun 20, 2025 | — |
| 144 | Notice of proposed sale | May 19, 2025 | — |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement
|
Feb 20, 2025 | Feb 19, 2025 |
| D/A | Filing | Feb 11, 2025 | — |
| 10-Q | Quarterly report | Nov 18, 2024 | Sep 30, 2024 |
| NT 10-Q | Filing | Nov 13, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 19, 2024 | Jun 30, 2024 |
| NT 10-Q | Filing | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 20, 2024 | Mar 31, 2024 |
| NT 10-Q | Filing | May 16, 2024 | Mar 31, 2024 |
| EFFECT | Filing | May 10, 2024 | — |
| EFFECT | Filing | May 10, 2024 | — |
| POS AM | Filing | May 8, 2024 | — |
| POS AM | Filing | May 8, 2024 | — |
| 8-K |
Current report
Other events
|
Apr 8, 2024 | Apr 2, 2024 |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| EFFECT | Filing | Feb 12, 2024 | — |
| EFFECT | Filing | Feb 12, 2024 | — |
| D | Filing | Feb 9, 2024 | — |
| CORRESP | Letter to the SEC | Feb 8, 2024 | — |
| CORRESP | Letter to the SEC | Feb 8, 2024 | — |
| POS AM | Filing | Feb 6, 2024 | — |
| 144 | Notice of proposed sale | Feb 5, 2024 | — |
| POS AM | Filing | Jan 18, 2024 | — |
| CORRESP | Letter to the SEC | Jan 17, 2024 | — |
| CORRESP | Letter to the SEC | Dec 29, 2023 | — |
| POS AM | Filing | Dec 29, 2023 | — |
| CORRESP | Letter to the SEC | Dec 29, 2023 | — |
| POS AM | Filing | Dec 29, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Dec 6, 2023 | Dec 4, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Dec 4, 2023 | Nov 30, 2023 |
| UPLOAD | Letter from the SEC | Nov 20, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2023 | — |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 144 | Notice of proposed sale | Nov 7, 2023 | — |
| POS AM | Filing | Nov 6, 2023 | — |
| POS AM | Filing | Nov 6, 2023 | — |
| 144 | Notice of proposed sale | Aug 31, 2023 | — |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 10-K/A | Amended annual report | Jun 15, 2023 | Dec 31, 2022 |
| UPLOAD | Letter from the SEC | Jun 13, 2023 | — |
| 10-Q/A | Amended quarterly report | May 30, 2023 | Mar 31, 2023 |
| UPLOAD | Letter from the SEC | May 23, 2023 | — |
| 10-Q | Quarterly report | May 18, 2023 | Mar 31, 2023 |
| NT 10-Q | Filing | May 16, 2023 | Mar 31, 2023 |
| UPLOAD | Letter from the SEC | May 2, 2023 | — |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 424B3 | Prospectus | Nov 28, 2022 | — |
| 424B3 | Prospectus | Nov 28, 2022 | — |
| 10-Q | Quarterly report | Nov 17, 2022 | Sep 30, 2022 |
| NT 10-Q | Filing | Nov 15, 2022 | Sep 30, 2022 |
| 424B3 | Prospectus | Sep 7, 2022 | — |
| 424B3 | Prospectus | Sep 7, 2022 | — |
| 10-Q | Quarterly report | Aug 19, 2022 | Jun 30, 2022 |
| NT 10-Q | Filing | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 28, 2022 | Jul 25, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Other events
|
Jul 7, 2022 | Jul 5, 2022 |
| EFFECT | Filing | Jun 21, 2022 | — |
| POS AM | Filing | Jun 21, 2022 | — |
| AW | Filing | Jun 21, 2022 | — |
| POS AM | Filing | Jun 13, 2022 | — |
| EFFECT | Filing | Jun 8, 2022 | — |
| POS AM | Filing | Jun 6, 2022 | — |
| POS AM | Filing | Jun 6, 2022 | — |
| 10-Q/A | Amended quarterly report | May 16, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | May 13, 2022 | Mar 31, 2022 |
| 10-K | Annual report | Apr 15, 2022 | Dec 31, 2021 |
| NT 10-K | Filing | Mar 31, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Material agreement
|
Feb 17, 2022 | Feb 14, 2022 |
| 424B3 | Prospectus | Feb 1, 2022 | — |
| EFFECT | Filing | Jan 31, 2022 | — |
| CORRESP | Letter to the SEC | Jan 27, 2022 | — |
| CORRESP | Letter to the SEC | Jan 26, 2022 | — |
| S-1/A | Amended registration statement | Jan 26, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 26, 2022 | — |
| S-1 | Registration statement | Jan 21, 2022 | — |
| 424B3 | Prospectus | Jan 21, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 30, 2021 | Dec 27, 2021 |
| 10-Q | Quarterly report | Nov 22, 2021 | Sep 30, 2021 |
| NT 10-Q | Filing | Nov 16, 2021 | Sep 30, 2021 |
| 424B3 | Prospectus | Oct 8, 2021 | — |
| EFFECT | Filing | Oct 7, 2021 | — |
| CORRESP | Letter to the SEC | Oct 5, 2021 | — |
| S-1/A | Amended registration statement | Oct 1, 2021 | — |
| S-1 | Registration statement | Aug 5, 2021 | — |
| CORRESP | Letter to the SEC | Aug 5, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2021 | — |
| D | Filing | Jul 1, 2021 | — |
| DRS/A | Filing | Jun 28, 2021 | — |
| DRSLTR | Filing | Jun 25, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2021 | — |
| DRS | Filing | Feb 16, 2021 | — |
Showing 114 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- RTGN (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Petaluma, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1836295
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.